B of A Securities Maintains Underperform on Core Laboratories, Lowers Price Target to $15
Benzinga Newsdesk 2 years ago
NewsPrice TargetAnalyst Ratings
B of A Securities analyst Chase Mulvehill maintains Core Laboratories (NYSE:CLB) with a Underperform and lowers the price target from $16 to $15.
B of A Securities analyst Chase Mulvehill maintains Core Laboratories (NYSE:CLB) with a Underperform and lowers the price target from $16 to $15.